MAKO Mako Surgical Corp. (MM)

MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Leerink Swann 2012 Global Healthcare Conference at the Waldorf Astoria in New York on Thursday, February 16 at 2:30 pm ET.

A webcast will be available and may be accessed by visiting MAKO's website at www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation. 

About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets its RIO® Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and proprietary RESTORIS® implants for orthopedic procedures called MAKOplasty®. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables precise, consistently reproducible bone resection for the accurate insertion and alignment of MAKO's RESTORIS implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications. Additional information can be found at www.makosurgical.com.

"MAKOplasty®," "RESTORIS®," "RIO®," as well as the "MAKO" logo, whether standing alone or in connection with the words "MAKO Surgical Corp." are trademarks of MAKO Surgical Corp.

CONTACT: Investors:
         MAKO Surgical Corp.
         954-628-1706
         investorrelations@makosurgical.com
         
         or
         
         Westwicke Partners
         Mark Klausner
         443-213-0500
         makosurgical@westwicke.com